This week, the consumer group Public Citizen filed a petition with the FDA demanding a Victoza recall be issued due to the serious side effects associated with this relatively new diabetes drug, which may increase the risk of thyroid cancer, kidney failure, pancreatitis and other injuries.

The product liability lawyers at Saiontz & Kirk, P.A. are reviewing whether former users of this medication who have experienced problems may be entitled to financial compensation through a Victoza lawsuit.

Public Citizen is urging the FDA to recall Victoza because it is now clear that the potential benefits provided by the diabetes drug are outweighed by the risk of Victoza side effects, which may include:

  • Thyroid Cancer
  • Kidney Failure
  • Pancreatitis
  • Hypersensitivity
  • Birth Defects or Malformations

Victoza (liraglutide) was approved by the FDA in January 2010 for the treatment of type 2 diabetes. Two of the FDA’s safety reviewers objected to its approval, due to danger signs that emerged during the clinical trials and the fact that there were already other diabetes drugs on the market, diminishing the need for a new one with potentially severe side effects.

Early testing in mice and rats showed signs of thyroid C-cell tumors in both sexes even when adjusting to simulate an adult taking the recommended dose. When the drug was given to humans in the pre-trial testing stage the rate of thyroid cancer tripled.

There were also early signs of problems with pancreatitis. People given the drug during clinical trials were almost four times as likely to be diagnosed with pancreatitis than patients given other diabetes drugs. After just a year and a half on the market, the FDA received 200 reports of Victoza users being diagnosed with pancreatitis. Many believe only about 10% of adverse events get reported to the FDA, which could mean there are thousands of cases of Victoza pancreatitis in the U.S.

Once the drug was on the market, reports of kidney failure from Victoza also began to roll in, and the FDA had to add yet another warning for acute renal failure to Victoza’s label. There were also warnings added later for hypersensitivity and an increased risk of Victoza birth defects and malformations when the drug was taken by pregnant women.


It appears that Novo Nordisk placed their desire for profits before consumer safety by marketing this diabetes drug without providing adequate warnings and ignoring signs of problems that should have led to a Victoza recall. As a result, about 150,000 prescriptions for Victoza are filled each month and individuals throughout the United States may have experienced injuries that may have been prevented with the use of a different diabetes drug.

The lawyers at Saiontz & Kirk, P.A. are considering potential lawsuits for individuals throughout the United States who may have developed thyroid cancer, kidney failure or pancreatitis. If you, a friend or family member has suffered any of these problems that may have been caused by side effects of Victoza, request a free consultation and claim evaluation.